Cargando…
An N(6)-methyladenosine-associated lncRNA signature for predicting clinical outcome and therapeutic responses in hepatocellular carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) is the leading cause of tumor-related mortality worldwide. N(6)-methyladenosine (m6A) and long noncoding RNAs (lncRNAs) have been reported to play significant roles in prognosis assessment and decision-making strategies for HCC. This study aimed to investig...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096396/ https://www.ncbi.nlm.nih.gov/pubmed/35571429 http://dx.doi.org/10.21037/atm-22-1583 |